Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
2007
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Genetic Structures at the Origin of Acquisition of the β-Lactamase bla KPC Gene
2008
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
2017
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and Outcomes
2008
Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae
2010
Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
2009
First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States
2008
First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase
2007
Presence of Plasmid-Mediated Quinolone Resistance in Klebsiella pneumoniae Isolates Possessing bla KPC in the United States
2008
Genomic Analysis of Hospital Plumbing Reveals Diverse Reservoir of Bacterial Plasmids Conferring Carbapenem Resistance
2018
Simple Disk-Based Method for Detection of Klebsiella pneumoniae Carbapenemase-Type β-Lactamase by Use of a Boronic Acid Compound
2008
Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae
2007
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
2006
Identification of Carbapenem-Resistant Klebsiella pneumoniae Harboring KPC Enzymes in New Jersey
2007
Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000–2004)
2006
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
2017
Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
2015
Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia
2014
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999–2005)
2006
Community acquisition of β-lactamase producing Enterobacteriaceae in neonatal gut
2013
Current status of carbapenemases in Latin America
2013
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant <em>Enterobacteriaceae</em>
2018
Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004
2005
Evaluation of prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization in veterinary personnel attending an international equine veterinary conference
2007
Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians
2012
Use of Active Surveillance Cultures to Detect Asymptomatic Colonization With Carbapenem-Resistant Klebsiella pneumoniae in Intensive Care Unit Patients
2008
Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006)
2007
Carbapenem resistance in Canada
2009
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Molecular mechanisms of antibiotic resistance
2014 Standout
Resistance in gram-negative bacteria: Enterobacteriaceae
2006
What's new in antibiotic resistance? Focus on beta-lactamases
2006
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance
2011
Extended-spectrum β-lactamases in North America, 1987–2006
2008
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program
2004
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)
2006
Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B
2005
Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals
2003
The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!
2005
Efflux pumps expression and its association with porin down-regulation and β-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil
2010
Prevalence and Risk Factors for Acquisition of Carbapenem-Resistant Enterobacteriaceae in the Setting of Endemicity
2013
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit
2006
The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species
2006
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel
2007
Transfer from High-Acuity Long-Term Care Facilities Is Associated with Carriage of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae: A Multihospital Study
2012
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination
2010
Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus
2008
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
The continuing challenge of ESBLs
2007
IRT and CMT β-lactamases and inhibitor resistance
2008
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
2007
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
2006
Emergence of Carbapenem Resistance inAcinetobacter baumanniiRecovered From Blood Cultures in Australia
2006
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
A Nosocomial Outbreak of Community‐Associated Methicillin‐Resistant Staphylococcus aureus among Healthy Newborns and Postpartum Mothers
2006
An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
2009
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
2008 Standout
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system
2009
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state
2010
A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005
2008
Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe
2010
Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns
2009
Drugs for bad bugs: confronting the challenges of antibacterial discovery
2006 Standout
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
What is in the pipeline for Gram-negative pathogens?
2008
Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008
2010
Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial
2007
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004)
2006
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
2017
Role of the Microbiota in Immunity and Inflammation
2014 Standout
The Science of Antibiotic Discovery
2020 Standout
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study
2007
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
2012
Infection with PanresistantKlebsiella pneumoniae:A Report of 2 Cases and a Brief Review of the Literature
2009
Prevalence of MRSA colonization in peripartum mothers and their newborn infants
2008
Outbreak by Ventilator-Associated ST11 K. pneumoniae with Co-production of CTX-M-24 and KPC-2 in a SICU of a Tertiary Teaching Hospital in Central China
2016
Emergence of Community-Associated Methicillin-ResistantStaphylococcus aureusInfection Among Patients With End-Stage Renal Disease
2006
Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat
2019
OXA-type carbapenemases
2006
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Resistance in Gram-Negative Bacteria: Enterobacteriaceae
2006
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
2006
Hospital-Based Strategies for Combating Resistance
2006
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
2008
Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases)
2013
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
2015 Standout
Carbapenem‐ResistantEscherichia coliHarboringKlebsiella pneumoniaeCarbapenemase β‐Lactamases Associated with Long‐Term Care Facilities
2008
Class A carbapenemases
2007
Clinical relevance of the ESKAPE pathogens
2013
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Dissemination of Community-Associated Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Hospital
2008
Streptococcus pneumoniae Bacteremia in Patients With Cancer
2005
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
2011 Standout
Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline
2006
Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital
2009
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
2010
Carbapenem-Resistant Enterobacteriaceae Infections in Children
2015
Prevalence, risk factors, and molecular epidemiology of methicillin-resistant Staphylococcus aureus among newly arrested men in Baltimore, Maryland
2008
Spread of methicillin‐resistant Staphylococcus aureus USA300 in a neonatal intensive care unit
2008
Risk Factors for Neonatal Methicillin-ResistantStaphylococcus aureusInfection in a Well-Infant Nursery
2007
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
2006
Pediatric Carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a High-prevalence Region in the United States
2014
Repetitive-DNA-element PCR fingerprinting and antibiotic resistance of pan-European multi-resistant Acinetobacter baumannii clone III strains
2005
Successful Eradication of a Monoclonal Strain ofKlebsiella pneumoniaeduring aK. pneumoniaeCarbapenemase-ProducingK. pneumoniaeOutbreak in a Surgical Intensive Care Unit in Miami, Florida
2010
Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge
2006
Proliferation and significance of clinically relevant β‐lactamases
2013
Ophthalmic Manifestations of Infections Caused by the USA300 Clone of Community-Associated Methicillin-Resistant Staphylococcus aureus
2006
In vitro activity of the -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
2009
Identification and Evolution of Drug Efflux Pump in Clinical Enterobacter aerogenes Strains Isolated in 1995 and 2003
2008
Spread of efflux pump-overexpressing, non-metallo-β-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity
2005
High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
2007
“Stormy waters ahead”: global emergence of carbapenemases
2013
Has the era of untreatable infections arrived?
2009
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
2010
Emergence of imipenem resistance in clinical Escherichia coli during therapy
2008
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
2009
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
2006
Successful Control of an Outbreak ofKlebsiella pneumoniaeCarbapenemase—ProducingK. pneumoniaeat a Long-Term Acute Care Hospital
2010
The changing epidemiology of resistance
2009
Tigecycline for Treatment of Pneumonia and Empyema Caused by Carbapenemase‐Producing Klebsiella pneumoniae
2007
Antibiotic susceptibility and mechanisms of β-lactam resistance among clinical strains of Pseudomonas aeruginosa: First report in Algeria
2008
OmpK35 and OmpK36 porin variants associated with specific sequence types ofKlebsiella pneumoniae
2013
Predictors and Outcomes for Pregnant Women with Vaginal-Rectal Carriage of Community-Associated Methicillin-Resistant Staphylococcus aureus
2007
Aminoglycosides: An Overview
2016
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
2007
Efflux-Mediated Drug Resistance in Bacteria
2009
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
2012 Standout
Efflux pumps as antimicrobial resistance mechanisms
2007
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)
2006
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Potential Role of Active Surveillance in the Control of a Hospital-Wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae Infection
2010
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
2006
Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007–2009 SENTRY Antimicrobial Surveillance Program
2013
The Spread ofKlebsiella pneumoniaeCarbapenemase–ProducingK. pneumoniaeto Upstate New York
2006
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)
2006
Staphylococcus aureusBloodstream Infections: Risk Factors, Outcomes, and the Influence of Methicillin Resistance in Calgary, Canada, 2000–2006
2008
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
2009 Standout
Inhibitors of bacterial virulence identified in a surrogate host model
2007
Interplay between β-lactamases and new β-lactamase inhibitors
2019
Antimicrobial susceptibility of extended-spectrum β-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial
2007
Dissemination of IMP-1 Metallo-β-Lactamase–Producing Acinetobacter Species in a Brazilian Teaching Hospital
2006
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases
2008
Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members
2007
Gram-negative antibiotic resistance: there is a price to pay
2008
Interhospital transfer of pan-resistant Acinetobacter strains in Johannesburg, South Africa
2004
Molecular mechanisms of antibiotic resistance
2011
High-Density Livestock Operations, Crop Field Application of Manure, and Risk of Community-Associated Methicillin-ResistantStaphylococcus aureusInfection in Pennsylvania
2013
Efflux-mediated antimicrobial resistance
2005
How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies
2010
Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention
2011
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum
2006
Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells
2005
KEGG as a reference resource for gene and protein annotation
2015 Standout
Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008)
2009
Community-associated meticillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit
2006
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals
2010
Resistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum
2006
Management of Community‐Associated Methicillin‐Resistant Staphylococcus aureus Infections in Children
2006
The New β-Lactamases
2005
Evaluation of CHROMagar KPC for Rapid Detection of Carbapenem-Resistant Enterobacteriaceae
2008
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Carbapenemase-Producing Enterobacteriaceae : now that the Storm is Finally here, how will Timely Detection help us Fight Back?
2012
Plazomicin: A Next‐Generation Aminoglycoside
2018
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Rapid Detection of bla KPC Carbapenemase Genes by Real-Time PCR
2008
Role ofampDHomologs in Overproduction of AmpC in Clinical Isolates ofPseudomonas aeruginosa
2008
Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)
2013
Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
2019
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
2012
High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression
2008
Optimal Surveillance Culture Sites for Detection of Methicillin-Resistant Staphylococcus aureus in Newborns
2006
Relevance of resistance levels to carbapenems and integron-borne bla IMP-1, bla IMP-7, bla IMP-10 and bla VIM-2 in clinical isolates of Pseudomonas aeruginosa
2009
Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center
2004
Antibiotic resistance is ancient
2011 StandoutNature
Updated Functional Classification of β-Lactamases
2009 Standout
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Genomewide Identification of Genetic Determinants of Antimicrobial Drug Resistance inPseudomonas aeruginosa
2009
Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management
2014
Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4
2008
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
2012
Temporal flux in β-lactam resistance among Klebsiella pneumoniae in Western Australia
2016
Identification of an OprD Homologue in Acinetobacter baumannii
2005
Plasmid-Mediated qnrB2 and Carbapenemase Gene bla KPC-2 Carried on the Same Plasmid in Carbapenem-Resistant Ciprofloxacin-Susceptible Enterobacter cloacae Isolates
2008
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
AmpC β-Lactamases
2009 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Distribution of Intrinsic Plasmid Replicase Genes and Their Association with Carbapenem-Hydrolyzing Class D β-Lactamase Genes in European Clinical Isolates of Acinetobacter baumannii
2011
Development and Evaluation of a Real-Time PCR Assay for Detection of Klebsiella pneumoniae Carbapenemase Genes
2008
First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America
2006
Vital signs: carbapenem-resistant Enterobacteriaceae.
2013
Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel
2006
Methicillin-resistant Staphylococcus aureus infections among healthy full-term newborns
2007
Antimicrobial Activities of Tigecycline and Other Broad-Spectrum Antimicrobials Tested against Serine Carbapenemase- and Metallo-β-Lactamase-Producing Enterobacteriaceae : Report from the SENTRY Antimicrobial Surveillance Program
2007
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals
2007
Community-Acquired Staphylococcus aureus Infections in Term and Near-Term Previously Healthy Neonates
2006
Effect of MexXY Overexpression on Ceftobiprole Susceptibility in Pseudomonas aeruginosa
2009
Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases,
2007
Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
2014
The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa
2006
Methicillin-Resistant Staphylococcus aureus at Canoe Camp
2006
Differences in Clinical and Molecular Characteristics of Skin and Soft Tissue Methicillin-Resistant Staphylococcus aureus Isolates between Two Hospitals in Northern California
2007
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
2018
Prevalence of Newer β-Lactamases in Gram-Negative Clinical Isolates Collected in the United States from 2001 to 2002
2006
First Report of the Emergence of CTX-M-Type Extended-Spectrum β-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System
2007
Deep Eutectic Solvents: A Review of Fundamentals and Applications
2020 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
Antimicrobial Susceptibility among Pathogens Collected from Hospitalized Patients in the United States and In Vitro Activity of Tigecycline, a New Glycylcycline Antimicrobial
2006
Differential Selection of Single-Step AmpC or Efflux Mutants of Pseudomonas aeruginosa by Using Cefepime, Ceftazidime, or Ceftobiprole
2010
Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1
2021 StandoutNobel
Emergence of Serratia marcescens , Klebsiella pneumoniae , and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC-2 in Intensive Care Units of a Chinese Hospital
2008
Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A β-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France
2008
Choline and Geranate Deep Eutectic Solvent as a Broad‐Spectrum Antiseptic Agent for Preventive and Therapeutic Applications
2016
Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality
2007
Polymyxin B and Doxycycline Use in Patients with Multidrug-Resistant Acinetobacter baumannii Infections in the Intensive Care Unit
2006
Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-Lactamase
2009
Channel Formation by CarO, the Carbapenem Resistance-Associated Outer Membrane Protein of Acinetobacter baumannii
2005
Methicillin-resistant Staphylococcus aureus: risk factors associated with community-onset infections in Denmark
2008
Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
2009
Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
2014
Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D
2007
Presence of the KPC Carbapenemase Gene in Enterobacteriaceae Causing Bacteremia and Its Correlation with In Vitro Carbapenem Susceptibility
2008
Establishment of In Vitro Susceptibility Testing Methodologies and Comparative Activities of Piperacillin in Combination with the Penem β-Lactamase Inhibitor BLI-489
2008
Synthetic Riboswitches That Induce Gene Expression in Diverse Bacterial Species
2010 StandoutNobel
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
2015
Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital
2007
Origins and Evolution of Antibiotic Resistance
2010 Standout
Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC β-Lactamase in P. mirabilis
2008
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Surveillance of Community-Based Reservoirs Reveals the Presence of CTX-M, Imported AmpC, and OXA-30 β-Lactamases in Urine Isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. Community
2008
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
2010 Standout
Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing
2016
Functional Characterization of Tn 4401 , a Tn 3 -Based Transposon Involved in bla KPC Gene Mobilization
2011
Molecular mechanisms of β-lactam resistance in carbapenemase-producing Klebsiella pneumoniae from Sri Lanka
2014
Detection of the Klebsiella pneumoniae Carbapenemase Type 2 Carbapenem-Hydrolyzing Enzyme in Clinical Isolates of Citrobacter freundii and K. oxytoca Carrying a Common Plasmid
2008
Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China
2006
Carbapenemases: Molecular Diversity and Clinical Consequences
2007
Kinetics Study of KPC-3, a Plasmid-Encoded Class A Carbapenem-Hydrolyzing β-Lactamase
2005
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
2011
Microbiota regulates immune defense against respiratory tract influenza A virus infection
2011 Standout
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
2003
Electronic Public Health Registry of Extensively Drug-Resistant Organisms, Illinois, USA
2015
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
2008
Plant and Animal Sensors of Conserved Microbial Signatures
2010 StandoutScienceNobel
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance
2019
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
2012
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
2009
Community-Acquired MRSA Infections in North Carolina Children: Prevalence, Antibiotic Sensitivities, and Risk Factors
2009
Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic Resistance
2012
Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa
2009
High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of bla ACT-1 β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE
2006
VIM-1 Metallo-β-lactamase inAcinetobacter baumannii
2006
Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 β-Lactamases
2009
Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China
2011
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Efflux Pumps, OprD Porin, AmpC β-Lactamase, and Multiresistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
2010
Inhibition of Class A β-Lactamases by Carbapenems: Crystallographic Observation of Two Conformations of Meropenem in SHV-1
2008
Works of Simona Bratu being referenced
A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City
2006
Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B
2005
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Acinetobacter baumannii Endemic in New York City
2003
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration
2012
Detection and Spread of Escherichia coli Possessing the Plasmid-Borne Carbapenemase KPC-2 in Brooklyn, New York
2007
Genetic relatedness of multidrug-resistantAcinetobacter baumanniiendemic to New York City
2008
Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae
2009
Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
2010
Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 -Lactamases in New York City
2004
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY
2007
Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City
2009
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents
2005
Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City
2005
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
2010
Emergence of KPC-Possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and Recommendations for Detection
2005
Detection of KPC Carbapenem-Hydrolyzing Enzymes in Enterobacter spp. from Brooklyn, New York
2005
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
2009
Correlation of Antimicrobial Resistance with β-Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City
2008
Streptococcus pneumoniae,Brooklyn, New York: Fluoroquinolone Resistance at our Doorstep
2002
Community-associated Methicillin-resistant Staphylococcus aureus in Hospital Nursery and Maternity Units
2005
Role of AmpD, OprF and penicillin-binding proteins in β-lactam resistance in clinical isolates of Pseudomonas aeruginosa
2007
Interplay of Efflux System, ampC , and oprD Expression in Carbapenem Resistance of Pseudomonas aeruginosa Clinical Isolates
2006
Evaluation of Techniques for Detection of Carbapenem-Resistant Klebsiella pneumoniae in Stool Surveillance Cultures
2005